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ANGIOGENIC ACTIVITY OF SUBCHONDRAL BONE INCREASES IN THE
EARLY STAGE OF OSTEOARTHRITIC KNEE
M. Saito, T. Sasho, S. Yamaguchi, N. Ikegawa, R. Akagi, Y. Muramatsu,
S. Mukouyama, K. Takahashi. Dept. of Orthopaedic Surgery, Graduate Sch.
of Med., Chiba Univesity, Chiba, Japan
Purpose: Angiogenesis is implicated as a cause of many diseases as well
as an inevitable repair process. In osteoarthritic (OA) knees, pathological
changes in the subchondral bone are considered to be related to disease
initiation, progression, and a potent source of knee pain. Previous studies
indicated that angiogenesis at the osteochondral junction might facilitate
the progression of OA. Despite the presence of vascular invasion into
the cartilage from the subchondral bone in end-stage OA knees, it is
largely unknown when vascular invasion occurs. Since vascular invasion
depends on the angiogenic activities of tissue, we hypothesized that there
might be a speciﬁc period with elevated angiogenic activities during the
development of OA.
The purpose of this study was to investigate the change of angiogenic
activities during the development of OA by biochemically and
histochemically in rabbit OA model.
Methods: OA was surgically induced by anterior cruciate ligament
transection (ACLT) in left knee of 12 months old female New Zealand
white rabbits. Contra lateral knees were sham operated. Animals were
necropsied at 2, 4, 6, 8, and 12 weeks postsurgery. Six animals were
allocated each time point. All the knees were examined macroscopically
and three rabbits for histological evaluation and three were for
angiogenic activity analysis. Histologic evaluation was performed with
hematoxylin and eosin, safranin-O staining.OA changes were evaluated
by the grading score of OARSI.
For angiogenic activity analysis subchondral bone and cartilage of the
medial femoral condyle (MFC) and those of lateral femoral condyle (LFC)
were obtained from each knee at each time point. The specimens were
co-cultured with human umblical vein endothelial cell (HUVEC) and
ﬁbroblasts using Angiogenesis Kit (KURABO, Osaka, Japan) for 11 days
according to the manufacturer’s instruction. After formation of the vessel
lumens were identiﬁed, the vessels were immunostained with anti-CD31
antibodies and four parameters concerning angiogenic activities, i.e. the
length, area, number of joints and paths of newly created vessels, were
analyzed automatically by Angiogenesis Image Analyzer (KURABO, Osaka,
Japan). To correct age and tissue speciﬁc angiogenic activities, each
parameter of OA knees was divided by corresponding sham operated
knees.
Results: The characteristic OA features were detected from 4 weeks in
MFC, and from 6weeks in LFC macroscopically and microscopically and
the grading score of OARSI increased time dependently.
The calculated parameters of the angiogenesis at subchondral bone of
MFC and LFC increased time dependently in the early period, however
it decreased at the later period. Angiogenic activities of MFC started
to increase at 4 weeks and increased to the peak at 6weeks. After the
peak, it took downward turn at 8weeks and decreased until 12weeks.
Those of LFC took the same tendency and started to increase at 6 weeks,
but started to decrease at 8weeks. On the other hand, the angiogenic
activity of cartilage had no changes during study period. This suggested
angiogenic activities of subchondral bone increased in the early to
moderate phase of OA when cartilage had been degenerated, and activity
decreased in the severe OA when cartilage had been lost.
Conclusions: Several previous studies reported that invasion of vascular
tissue from the subchondral bone into the cartilage was related with
degeneration of articular cartilage. This study indicated that the peak
of the angiogenic activities of subchondral bone was in the early stage
of OA and presumably followed by the invasion of vascular tissue into
the cartilage. This result might implicate new OA treatment in terms of
angiogenesis.
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Purpose: To examine the effect of the chondrocyte-derived extracellular
matrix (CD-ECM) on the vessel formation in vitro and in a nude mice
model.
Method: Human umbilical vein endothelial cells (HUVECs) were plated
on a bio-membrane made of CD-ECM or human amniotic membrane
(HAM) in vitro. The adhesion, proliferation and tube formation activity
of HUVECs were examined. Then, the CD-ECM and HAM powders were
mixed individually in Matrigel and injected subcutaneously into nude
mice in vivo. The vessel invasion into the Matrigel was examined after
1 week.
Results: The adhesion and proliferation of HUVECs were more efﬁcient
on the HAM membrane than on the CD-ECM membrane. The endothelial
cells exposed to HAM membrane had signiﬁcant increase in growth
compared to the CD-ECM membrane at all experiment period (Fig. 1a).
Fig. 1. Inﬂuence of the chondrocyte-derived ECM (CD-ECM) on the cell
adhesion, proliferation and tube-forming ability of human umbilical
vein endothelial cells (HUVECs). (a) Cell adhesion and proliferation on
membranes made of CD-ECM and human amniotic membrance (HAM).
(b) Tube formation assay on basement membrane matrix/CD-ECM and
HAM powder.
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Fig. 2. Gross observation and histology of retrieved samples from the
in vivo experiment. (a) The implanted specimens (n =5/time point/
group) were retrieved at 1 week after implantation. The gross images
of specimen were presented vessel invasion in vivo. (b) The sections
were stained with hematoxylin/eosin and alpha smooth muscle actin to
observed vessel invasion. Scale bar: 1mm for 20× and 200mm for 400×
image.
Fig. 3. Immunostaining of in vivo specimens for CD31 and VEGF-A. The
retrieved specimens at 1 week were immunostained CD31, VEGF-A to
observed vessel invasion. Scale bar: 200 mm for 400× image.
Tube formations of HUVECs were signiﬁcantly reduced on a basement
membrane matrix containing the ECM powder in their vicinity than
basement membrane matrix containing the HAM powder (Fig. 1b). In
the nude mice model, the vessel invasion also occurred more deeply and
intensively in Matrigel containing HAM than in the one containing CD-
ECM (Fig. 2a). Also, express of alpha smooth muscle actin was observed
in the broad central area, similar to H&E stain in Matrigel containing
HAM. However, Matrigel containing CD-ECM was not observed vessel-
like structures (Fig. 2b). In the immunostaining the expression of CD31, an
endothelial cell marker was not expressed in the ECM powder/Matrigel,
while expressed in the whole region of the HAM powder/Matrigel. The
expression of VEGF-A also showed a positive stain in the whole region
of the HAM powder/Matrigel samples
Conclusion: These results suggest that the extracellular matrix material
from chondrocytes has potential to inhibit vessel invasion in vitro and
in vivo.
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LYSYL HYDROXYLASE 2B IS STRONGLY INDUCED DURING
EXPERIMENTAL OA AND THE POTENTIAL CAUSE OF PERSISTENT
SYNOVIAL FIBROSIS
D. Remst1, E. Blaney Davidson1, E. Vitters1, R. Bank2, W. van den Berg1,
P. van der Kraan1. 1Radboud Univ. Med. Ctr., Nijmegen, Netherlands; 2Univ.
Groningen, Groningen, Netherlands
Purpose: Fibrosis is a major contributor to stiffness in osteoarthritis (OA)
and associated with joint pain. Lysyl hydroxylase 2b (LH2b) increases
pyridinoline cross-links during collagen synthesis. These cross-links are
harder to degrade than “normal” cross-links and are elevated during
different ﬁbrotic diseases. In previous studies we found a relationship
between LH2b and irreversible ﬁbrosis after TGF-b exposure in murine
knee joints. Furthermore, we showed that TGF-b induced LH2b gene
expression in human synovial OA ﬁbroblasts (hSF). In this study
we examined whether LH2b is actually induced in experimental OA.
Thereafter we investigated which TGF-b signaling route is involved in
up regulation of LH2b expression and whether gene expression also
translates into LH2 protein production by TGF-b in hSF.
Methods: To induce OA we injected of bacterial collagenase into the
right knee joint of C57BL/6 mice. The mice were sacriﬁced at day 7, 21
and 42 after collagenase injection and the mRNA was isolated from the
synovium for Q-PCR analysis. Human synovium ﬁbroblast were isolated
from knee joints of OA patients undergoing arthroplasties. The hSF were
transduced with adenoviruses overexpressing TGF-b (Ad-TGF-b), CTGF
(Ad-CTGF) or Luc (Ad-Luc) to determine whether the LH2b induction
is a TGF-b speciﬁc effect, as found in mice. Thereafter, the hSF were
stimulated with TGF-b with and without ALK5 or ALK1 kinase inhibitor,
SB-505124 (SB) or dorsomorphin (DM) respectively. In addition, cells
were transduced with constitutive active TGF-b type I receptors, Ad-
caALK1 or Ad-caALK5 to determine whether LH2b expression is ALK1
or ALK5 speciﬁc. RNA was isolated and the gene expression for LH1, -2
and -3, lysyl oxidase (LOX), collagen type 1A1 (COL 1A1), and CTGF was
analyzed with RT-PCR. LH2 protein level was determined with Western
Blot analysis.
Results: In murine experimental OA there was a signiﬁcant and long-
lasting increase of LH2b gene expression in the synovium on day 7, 21
and 42 compared to the control knee joints (ﬁgure 1A). In hSF Ad-TGF-b
induced LH2b gene expression whereas Ad-CTGF did not, comparable
to our observations in murine synovium. TGF-b stimulation induced
LH2b, CTGF, COL1A1 and LOX gene expression as well as LH2 protein
(ﬁgure 1B).
Fig. 1. (A) LH2b gene expression measured in mRNA isolated from
the synovium of murine knee joints with collagenese induced OA. The
LH2b gene expression was signiﬁcantly induced in the OA-affected joint
compared to the healthy joints on al measured days (day 7, 21 and 42).
(B) Human synovial ﬁbroblasts were cultured in the presence or absence
of TGF-b for 24 h and 48 h. A strong increase in LH2 protein level was
observed after both 24h and 48h TGF-b stimulation.
No major changes in LH1 and LH3 gene expression were found.
Ad-caALK5 but not Ad-caALK1 signiﬁcantly induced LH2b. This was
conﬁrmed by SB completely blocking TGF-b induced LH2b, while LH2b
gene expression was only slightly decreased by DM. Identical results
were observed for all ﬁve primary ﬁbroblast cell cultures.
Conclusions: In this study we have shown that LH2b is strongly
induced in an experimental OA model that is accompanied by synovial
ﬁbrosis. Furthermore, we showed that both LH2b gene expression and
LH2 protein are induced by TGF-b in hSF. Overexpressing caALK5, the
canonical TGF-b type I receptor, induced LH2b, whereas blocking ALK5
kinase activity prevented TGF-b induced LH2b. The overexpression of
caALK1 did not alter LH2b gene expression, indicating TGF-b-induced
LH2b relies on ALK5 signaling alone. During OA, TGF-b is elevated causing
enhanced LH2b expression. LH2b increases pyridinoline cross-links in
collagen. We therefore propose that LH2b will be responsible for the
persistence of ﬁbrosis during OA. Selective blocking of LH2b in OA may
prevent the formation of the pyridinoline cross-links, and therefore the
formation of persistent ﬁbrosis. Thus LH2b is a highly interesting new
target to treat OA-related ﬁbrosis.
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EFFECT OF REMOBILIZATION ON IMMOBILIZATION-INDUCED JOINT
CONTRACTURE IN RAT KNEE JOINTS
A. Ando, H. Suda, Y. Hagiwara, Y. Onoda, E. Chimoto, E. Itoi. Tohoku Univ.
Sch. of Med., Sendai, Japan
Purpose: Joint immobilization is commonly used for the treatment of
many musculoskeletal disorders, but it also causes joint contracture.
Recent studies suggested that a joint capsule, which belongs to
arthrogenic components, is a main cause of joint contracture. In
our previous reports, immobilization induced restriction in range of
